Detectability of Retinal Diffusion Restriction in Central Retinal Artery Occlusion is Linked to Inner Retinal Layer Thickness.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 13 08 2021
accepted: 05 04 2022
pubmed: 4 5 2022
medline: 15 12 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

To investigate retinal microstructure differences in central retinal artery occlusion (CRAO) patients with and without visible retinal diffusion restriction (RDR) on diffusion-weighted magnetic resonance imaging (DWI). Consecutive CRAO patients with available optical coherence tomography (OCT) and DWI, both performed within 7 days after symptom onset, were included in a retrospective cohort study. The OCT scans were reviewed to assess retinal layer thickness, optical intensity and structural integrity. The OCT findings were compared between patients with and without visible RDR on DWI using Mann-Whitney U or Pearson's Χ A total of 56 patients (mean age 70.8 ± 12.8 years) were included. RDR was observed in 38 subjects (67.9%) with visually correlating low ADC map in 26 of 38 cases (68.4%). Superior and inferior parafoveal macular thickness measurements (SMT, IMT) of RDR negative patients were significantly lower when compared to RDR+ patients (370.5 ± 43.8 µm vs. 418.2 ± 76.0 µm, p = 0.016; 374.4 ± 42.9 µm vs. 428.8 ± 63.2 µm, p = 0.004) due to differences in inner retinal layer thickness (IRLT, 188.8 ± 34.4 µm vs. 234.7 ± 49.0 µm, p = 0.002). IRLT values of RDR negative patients were higher in 1.5T compared to 3T the DWI (205.0 ± 26.0 µm vs. 168.6 ± 32.8 µm, p = 0.026). Detectability of RDR is likely contingent upon the degree of ischemic retinal swelling in CRAO. Technical adjustments to the DWI protocol, such as increased field strength, may improve visibility of RDR.

Identifiants

pubmed: 35503466
doi: 10.1007/s00062-022-01168-9
pii: 10.1007/s00062-022-01168-9
pmc: PMC9744698
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1037-1044

Informations de copyright

© 2022. The Author(s).

Références

Retina. 2016 Oct;36(10):1964-70
pubmed: 26966866
Am J Ophthalmol. 2015 Apr;159(4):667-76
pubmed: 25579642
Acta Ophthalmol. 2021 Mar;99(2):e247-e252
pubmed: 32767551
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Indian J Ophthalmol. 2018 Dec;66(12):1684-1694
pubmed: 30451166
Neuroophthalmology. 2017 Oct 13;42(3):191-193
pubmed: 29796056
Acta Ophthalmol. 2020 Sep;98(6):e680-e684
pubmed: 32040258
Clin Imaging. 2020 Feb;59(2):126-128
pubmed: 31816539
Eur J Med Res. 2006 Jun 30;11(6):250-2
pubmed: 16820338
Sci Rep. 2021 Oct 15;11(1):20538
pubmed: 34654843
Retina. 2011 Apr;31(4):730-7
pubmed: 21242861
Clin Neuroradiol. 2021 Sep;31(3):619-626
pubmed: 32936308
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487
N Engl J Med. 2019 May 9;380(19):1795-1803
pubmed: 31067369
AJNR Am J Neuroradiol. 2021 Sep;42(9):1661-1666
pubmed: 34266868
Clin Ophthalmol. 2020 Aug 24;14:2453-2462
pubmed: 32921978
Arch Ophthalmol. 1968 Apr;79(4):453-69
pubmed: 4966522
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40
pubmed: 16505064
J Fr Ophtalmol. 2012 Oct;35(8):606-13
pubmed: 22819341
Retina. 2007 Mar;27(3):276-89
pubmed: 17460582
Stroke. 2020 Jul;51(7):2018-2025
pubmed: 32568646
Neurologist. 2017 May;22(3):77-79
pubmed: 28471894
Br J Ophthalmol. 2012 Feb;96(2):201-7
pubmed: 21515559
Retina. 2013 Nov-Dec;33(10):2110-7
pubmed: 23594722
Sci Rep. 2015 Mar 18;5:9269
pubmed: 25784298
Retina. 2006 Jan;26(1):110-2
pubmed: 16395151
J Ophthalmol. 2011;2011:764183
pubmed: 21969910

Auteurs

E Siebert (E)

Institute of Neuroradiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

M Rossel-Zemkouo (M)

Department of Ophthalmology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

K Villringer (K)

Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

K Neumann (K)

Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

G Bohner (G)

Institute of Neuroradiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

L A Danyel (LA)

Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. leon.danyel@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH